Clinical Trial: D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

Brief Summary: This study is a placebo-controlled 12 week trial of DCS augmentation of once-weekly CBT sessions in 60 schizophrenia subjects with antipsychotic-resistant delusions. In addition to testing efficacy, this trial will characterize DCS effects in terms of time course and persistence of response and will examine DCS effects on memory consolidation and cognitive flexibility as possible mediators of DCS enhancement of CBT for delusions.